mifepristone has been researched along with Neuroendocrine Tumors in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Felizola, SJ; Kasajima, A; Motoi, F; Nakamura, Y; Ogata, H; Onodera, Y; Sasano, H; Unno, M; Watanabe, M; Yazdani, S | 1 |
1 other study(ies) available for mifepristone and Neuroendocrine Tumors
| Article | Year |
|---|---|
Progesterone Receptor Isoforms A and B in Pancreatic Neuroendocrine Tumor.
Topics: Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Proliferation; Female; Hormone Antagonists; Hormones; Humans; Male; Middle Aged; Mifepristone; Neuroendocrine Tumors; Pancreatic Neoplasms; Progesterone; Protein Isoforms; Receptors, Progesterone | 2015 |